Dentsply International Given Average Rating of “Buy” by Brokerages (NASDAQ:XRAY)
Dentsply International (NASDAQ:XRAY) has received an average recommendation of “Buy” from the seven brokerages that are covering the company, Analyst Ratings.Net reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $51.00.
Shares of Dentsply International (NASDAQ:XRAY) opened at 45.87 on Monday. Dentsply International has a one year low of $41.31 and a one year high of $50.99. The stock’s 50-day moving average is $47.19 and its 200-day moving average is $46.35. The company has a market cap of $6.503 billion and a P/E ratio of 21.38.
Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.69 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.68 by $0.01. The company had revenue of $765.20 million for the quarter, compared to the consensus estimate of $782.86 million. During the same quarter in the prior year, the company posted $0.66 earnings per share. The company’s quarterly revenue was up .6% on a year-over-year basis. Analysts expect that Dentsply International will post $2.52 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a dividend of $0.0663 per share. This represents a $0.27 annualized dividend and a dividend yield of 0.58%. The ex-dividend date is Wednesday, September 24th.
A number of analysts have recently weighed in on XRAY shares. Analysts at Zacks reiterated a “neutral” rating on shares of Dentsply International in a research note on Friday, August 1st. They now have a $49.00 price target on the stock. Analysts at Barrington Research upgraded shares of Dentsply International from a “market perform” rating to an “outperform” rating in a research note on Friday, May 16th.
DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.